DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Lynne Chou O'Keefe - 3 It's - 2 Siva Namasivayam - 1 Cohere - 1 Axios - 1 Namasivayam - 1 Michael Greeley - 1 Greeley - 1
Top related locs:
Deerfield Cohere
Top related orgs:
Define Ventures - 2 Cohere - 1 Business - 1 Deerfield Management - 1 Flare Capital - 1 Longitude - 1 Polaris Partners - 1 Humana - 1

Search resuls for: "Lynne Chou O'Keefe"


3 mentions found


☆ Exclusive: AI healthcare software startup Cohere Health just raised $50 million
  + stars: | 2024-02-01 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +4 min
Cohere Health just landed $50 million in Series B extension funding, Business Insider has learned exclusively. Deerfield Management led the Series B extension, with participation from Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners. The Cohere Health team. This year, as it works to get more health plans to use its software, Cohere plans to grow its workforce. In the second quarter of this year, Cohere plans to announce software that will apply AI to medical imaging.
Persons: Siva Namasivayam, Cohere, Axios, Namasivayam, It's, Michael Greeley, Lynne Chou O'Keefe, Greeley, Cohere's Organizations: Cohere, Business, Deerfield Management, Define Ventures, Flare Capital, Longitude, Polaris Partners, Humana, Capital Partners, Cohere Health Locations: Deerfield, Cohere
☆ 25 healthcare startups that are set to take off in 2024, according to top VCs
  + stars: | 2023-12-18 | by ( Rebecca Torrence | Blake Dodge | ) www.businessinsider.com   time to read: +1 min
AetionAetion's website. AetionPicked by: Lynne Chou O'Keefe, the founder and managing partner of Define VenturesWhat the company does: Aetion provides pharmaceutical companies, payers, and regulators with real-world evidence they can use to inform decisions. Aetion provides the real-world evidence that insurers, pharmaceutical companies, and regulatory agencies need to evaluate the value of drugs and inform those conversations, she said. "The cost of specialty drugs, what's happening in the Inflation Reduction Act — all are bellwethers that we need a more value-based-oriented system around therapeutics going forward," she said. — Shelby Livingston
Persons: Aetion, Lynne Chou O'Keefe, O'Keefe, — Shelby Livingston
☆ Healthcare VCs are focusing their bets on a handful of top startups, forcing the rest to scramble to stay afloat
  + stars: | 2023-07-10 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +6 min
In the first half of 2023, healthcare investors have written big checks for their top startup picks. 2023 is on track to be the lowest year of healthcare funding since 2019, Rock Health says. Digital-health startups in the US raised $6.1 billion in the first half of 2023, Rock Health's H1 2023 funding report published on Monday found. Right now, 2023 is on track to be the lowest healthcare funding year since 2019, according to Rock Health. Krasniansky said Rock Health expects many of the impending shutdowns to impact healthcare startups that sell products and services to patients online and on-demand, especially direct-to-consumer companies like telemedicine or mail-order-pharmacy startups.
Persons: It's, haven't, Healthcare's, healthcare's, Adriana Krasniansky, Krasniansky, Ian Chiang, he's, Lynne Chou O'Keefe, it's, Corey McCann, Chou O'Keefe, — Organizations: Rock Health, megadeals, Monogram Health, Frist Cressey Ventures, Flare Capital Partners, Define Ventures, Pear, Madison, Pear Therapeutics
0 next >>
Total: 3